NAD+ injections for energy deliver nicotinamide adenine dinucleotide, a coenzyme your cells use to convert food into usable fuel, directly under the skin, bypassing digestion. People typically use them to address low energy, mental fog, and post-exertion fatigue, and some report feeling steadier within the first few weeks, though controlled trials haven't established that injected NAD+ produces those effects. The mechanism is well established, but rigorous human trials on injected NAD+ specifically are still limited, so it's best understood as a promising option under provider supervision rather than a proven treatment.

You'll see the same thing marketed as an NAD plus injection or as NAD shots for energy. Here's what the science supports, what a real protocol looks like, and what people report week by week. This article is educational and isn't medical advice.

Why NAD+ levels affect energy

Every cell in your body runs on ATP, and making ATP requires NAD+. Think of NAD+ as the shuttle that carries electrons through your mitochondria, the compartments inside cells where fuel becomes energy. Without enough shuttles, the production line slows down even when raw materials are plentiful.

NAD+ does a second job, too. It's the required substrate for sirtuins and PARP enzymes, which handle DNA repair and cellular stress responses. When those systems are working overtime, from illness, inflammation, poor sleep, or heavy training, they consume NAD+ that would otherwise go toward energy production. That competition is one plausible explanation for why fatigue often accompanies periods of high physical or metabolic stress.

The popular claim is that NAD+ falls steadily with age. That's where the science gets more nuanced than most marketing admits. Several studies have found lower NAD+ in aging tissue, including skin and skeletal muscle. But whole-blood NAD+ measured across seven separate human cohorts stayed remarkably stable with age and did not shift with lifestyle interventions [1]. The likely explanation is that blood is a poor window into what's happening inside specific tissues, and that tissue-level data in humans remains sparse.

If you want the fuller picture on that debate, we cover it in how NAD+ levels change with age.

What the research shows about NAD injections for energy

Here's the state of the evidence, stated plainly.

Precursors reliably raise NAD+. In a randomized, placebo-controlled crossover trial, 24 healthy adults aged 55 to 79 took either 1,000 mg/day of nicotinamide riboside or placebo for six weeks; NAD+ in their immune cells rose roughly 60%, and the supplement was well tolerated [2]. Notably, though, most functional measures (insulin sensitivity, resting metabolic rate, VO₂ max, and motor function) did not change [2].

Some functional signals do appear. In a 60-day randomized, multicenter, dose-ranging trial, 80 healthy middle-aged adults took 300, 600, or 900 mg of NMN daily or placebo. Blood NAD levels rose significantly in every treated group, and six-minute walking distance improved significantly versus placebo, most clearly in the 600 mg and 900 mg groups. No safety issues emerged up to 900 mg daily [3].

The route matters, and injectable data is thin. Most of the human evidence involves oral precursors, not injected NAD+ itself. A review of the human trials concluded that despite promising preclinical work, NAD+ precursors have shown limited efficacy in people, and that evidence for age-related NAD+ decline in humans is inconsistent [4]. There is no large body of randomized trial data on subcutaneous NAD+ injections for energy in otherwise healthy adults.

What that adds up to: raising NAD+ is achievable and appears safe in supervised settings. Whether it produces meaningful, lasting improvement in how energetic you feel is still an open question that varies from person to person, which is why medical oversight and follow-up matter more than any protocol on paper.

What a typical protocol looks like

Injections are usually given subcutaneously (a small needle into fat tissue, similar to an insulin pen), which you can do at home after a brief training session.

In clinical practice, starting doses commonly fall in the range of 50–100 mg per injection, given a few times per week during an initial loading period, then reduced to a lower maintenance frequency. Some people do better with smaller, more frequent doses; others tolerate less frequent, larger ones.

Those numbers are context, not a prescription. Your provider determines your dose and schedule based on your history, symptoms, body weight, medications, and how you respond over the first several weeks. There is no universal NAD+ dose, and any program that assigns one without evaluating you first is skipping the part that actually matters.

A well-run program starts low, titrates, and builds in scheduled check-ins to adjust, with any lab work arranged through your own provider or physician. Injectable NAD+ is dispensed as a compounded prescription medication, which means it isn't FDA-approved and the FDA doesn't evaluate it for safety, effectiveness, or quality.

Timeline: What people report over time

Reported timelines vary a great deal. The patterns below are what people self-report and what providers commonly hear; they are not results demonstrated in controlled trials, and they are easily confounded by placebo and by the other changes people make when starting a program, such as better sleep and more attention to diet.

Timeframe What people typically report
Week 1 Little to nothing, or mild injection-site redness. Some notice slightly better sleep. A few describe a short-lived lift after each dose.
Weeks 2–4 The window in which people most often report a change, such as steadier afternoon energy, less mental fog, or easier recovery after exercise. None of this is established in trials.
Weeks 6–12 Among people who report a benefit, it tends to feel less like a boost and more like a steadier baseline. This is when providers usually reassess and adjust.
Beyond 12 weeks Maintenance dosing. If you've felt no meaningful change by this point, that's useful information; it may be time to look at other causes of fatigue.

Two honest caveats. First, fatigue responds strongly to placebo and to the other changes people make when starting a program. Second, and more important: persistent fatigue deserves a real workup. Thyroid dysfunction, iron deficiency, sleep apnea, depression, and anemia are common, treatable, and frequently missed. NAD+ is not a substitute for finding out why you're tired.

Injections vs IV vs oral supplements

Route Practical reality
Subcutaneous injection At-home, minutes per dose, no clinic visits. Avoids digestion. Least expensive of the two injectable routes; tolerability generally good.
IV infusion Delivers a larger dose but requires clinic time and is often poorly tolerated. In a small real-world pilot study, six participants who received 500 mg of NAD+ intravenously reported moderate-to-severe cramping, nausea, and chest pressure during infusion, symptoms that resolved as soon as the infusion ended; infusions averaged 97 minutes because patients slowed their own drip rate [5].
Oral NAD+ and precursors Most convenient and best-studied, particularly NMN and NR. NAD+ itself is poorly absorbed orally; precursors are the sensible oral choice.

For a detailed side-by-side, see our comparison of NAD+ injections vs oral drops vs nasal spray.

Side effects and who should avoid it

Subcutaneous NAD+ is generally well tolerated. Most reported effects are mild and short-lived:

  • Redness, itching, or a small lump at the injection site
  • Flushing or a warm sensation shortly after dosing
  • Mild nausea or a brief headache
  • Transient fatigue after the first few doses

Severe reactions are uncommon with subcutaneous dosing; the cramping and chest pressure seen with IV infusion largely reflect how fast the dose enters the bloodstream. Slower delivery generally means better tolerance.

You should not start NAD+ injections without provider clearance if you:

  • Are pregnant, trying to conceive, or breastfeeding, since safety data is absent
  • Have an active or recent cancer diagnosis, since NAD+ metabolism intersects with cell proliferation pathways
  • Have significant kidney or liver disease
  • Take medications with a narrow therapeutic window, or are on chemotherapy or immunosuppressants
  • Have an unexplained new symptom (for example, fatigue that appeared suddenly, with weight loss, fever, or shortness of breath), which needs a diagnosis first

Stop and contact your provider for any rash, swelling, difficulty breathing, or chest pain.

Frequently asked questions

How long do NAD+ injections take to work?
Among people who report a change, it's usually in weeks 2 to 4, though this hasn't been established in controlled trials. A same-day lift is usually not the NAD+ itself. If nothing has changed by around 12 weeks at an appropriate dose, that's a signal to revisit the underlying cause of your fatigue with your provider.

Are NAD+ injections better than oral NMN or NR?
Not necessarily better, just different. Injections bypass digestion and absorption variability, which is their main advantage. Oral precursors have substantially more randomized trial data behind them. The best choice depends on your goals, budget, and whether you're comfortable self-injecting; it's a reasonable conversation to have with a provider.

Do I need bloodwork before starting?
Most providers will want it, and any bloodwork is arranged through your own provider or physician. Fatigue has many common, treatable causes, so a baseline panel both screens for them and gives you a reference point for follow-up. A provider willing to prescribe for fatigue with no labs at all is skipping the most important step.

Next steps

If low energy is what's prompting you to look at NAD+, the most useful first step is finding out why you're tired, not starting an injection on faith. With Luvo, you complete a short intake questionnaire (about two minutes) covering your energy patterns, sleep, health history, and medications. A licensed provider reviews it and decides whether NAD+ is appropriate or whether something else explains your symptoms; nothing is prescribed or shipped without that review. If it's approved, you start at a conservative dose with medication shipped from a licensed compounding pharmacy, and your provider adjusts it through scheduled check-ins. Any lab work, such as thyroid, ferritin, or a metabolic panel to rule out common causes of fatigue, is arranged through your own provider or physician.

Explore Luvo's Longevity Program.

Sources

  1. Human whole-blood NAD+ levels do not vary with age or lifestyle interventions. Nature Metabolism. 2026;8:1282–1290. doi:10.1038/s42255-026-01537-5.
  2. Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications. 2018;9:1286. doi:10.1038/s41467-018-03421-7.
  3. Yi L, et al. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. 2023. PMID: 36482258.
  4. NAD+ precursor supplementation in human ageing: clinical evidence and challenges. Nature Metabolism. 2025. doi:10.1038/s42255-025-01387-7.
  5. Reyna R, et al. Intravenous infusion of nicotinamide adenine dinucleotide (NAD+) versus nicotinamide riboside (NR): a retrospective tolerability pilot study in a real-world setting. Frontiers in Aging. 2026. doi:10.3389/fragi.2026.1652582.
This article is for educational purposes only and is not medical advice. Some therapies referenced are compounded and not FDA-approved. Always consult a licensed healthcare provider to determine whether any treatment is appropriate for you.